Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
link
photo
Tags
antisense oligonucleotide
benzodiazepines
biogen
biotech
blackstone group
blackstone life sciences
boston
boston blog main
boston top stories
clinical trials
columbia university
david goldstein
depression
epi4k
epilepsy
essential tremor
investing
kiran reddy
life sciences
major depressive disorder
marcio souza
national blog main
national top stories
new york blog main
new york top stories
perimenopausal depression
praxis precision medicines
ptc therapeutics
startups
steven petrou
third rock ventures
university of melbourne
venture capital
What
drugs
2
×
links
2
×
new
research
aims
backed
bad
catches
cause
ceo
contributed
data
document
drug
effects
epilepsy
extreme
falsified
faulty
fda
figure
genes
genetic
goes
good
hide
impossible
issues
lapses
lengths
letter
marcio
medical
medicines
mutations
nearly
negligence
neuro
particular
praxis
Language
unset
Current search:
links
×
drugs
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@WIRED
9 years ago
Whenever the FDA catches falsified data or unreported side effects, it issues a warning letter to document the bad research. That’s good. But a new study shows...